rI CNA CPG
CPG for incorporation of unmodified inosine at 3' end of an oligonucleotide.
CPG for incorporation of unmodified inosine at 3' end of an oligonucleotide.
CPG column used to incorporate a deoxyuridine base into the 3' end of an oligonucleotide.
CPG column used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG column used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
Phosphoramidite used to replace thymidine residues in oligonucleotides, for duplex stabilization.
Phosphoramidite used to incorporate a 8-oxo-modified deoxyguanosine into an oligonucleotide.
Allows for incorporation of a halogenated nucleoside into oligonucleotides for crystallographic studies and crosslinking studies of protein-DNA and RNA-DNA complexes.
Phosphoramidite used to incorporate an anthraquinone pyrrolidine moiety into an oligonucleotide.
Phosphoramidite used to incorporate a 5-hydroxy-modified deoxycytidine into an oligonucleotide for epigenetic studies.
Half of a novel base pair (with d5SICS) that achieves pair recognition through hydrophobic interactions.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |